Overvægt kliniske forsøg i Texas
81 studier for Overvægt søger deltagere på steder i Texas.
Byer i Texas
- Houston43 studier
- San Antonio40 studier
- Dallas30 studier
- Austin20 studier
- Grand Prairie13 studier
- The Woodlands12 studier
- Sugar Land11 studier
- Amarillo10 studier
- El Paso10 studier
- Pharr10 studier
- Mesquite8 studier
- Brownsville7 studier
- Fort Worth6 studier
- Corpus Christi6 studier
- Round Rock4 studier
- Plano4 studier
- McKinney4 studier
- Lubbock3 studier
- Denison3 studier
- McAllen3 studier
- Wichita Falls3 studier
- Garland3 studier
- League City3 studier
Officiel studietekst (engelsk)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Amarillo Medical Specialists /ID# 282380, Amarillo
- Elligo Clinical Research Center /ID# 282166, Austin
- JCCT - Juno Bellaire /ID# 282263, Bellaire
- og 4 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07752979A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
- Kailera Clinical Site, San Antonio
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 85 · Alle køn · Opdateret 1. okt. 2026 · NCT07793929A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Horizon Clinical Research Group, Cypress
- Cardiovascular Specialists of Willowbrook, Houston
- Texas Cardiology Associates of Houston, Kingwood
- og 2 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802Spinal Cord Injury Model Systems (SCIMS) - Education Module
- Baylor Scott & White Institute for Research, Dallas
Rekrutterer
Alder 18 til 70 · Alle køn · Opdateret 30. sep. 2026 · NCT06003686AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- UT Southwestern Med Center, Dallas
- PlanIt Research, PLLC, Houston
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- DM Clinical, Houston
- DM Clinical, San Antonio
- The Texas Liver Institute, San Antonio
- og 3 flere
RekruttererFase 3
Alder 8 til 18 · Alle køn · Opdateret 30. sep. 2026 · NCT07253285AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Amarillo Medical Specialists, Amarillo
- North Texas Endocrine Center, Dallas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07720271Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
- Endeavor Clinical Trials, San Antonio
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 28. sep. 2026 · NCT07399678A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Amarillo Med Spec LLP, Amarillo
- Texas Diabetes & Endocrinology, Austin
- Pinnacle Clinical Research, Brownsville
- og 7 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07668414A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
- VIP Trials, San Antonio
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Houston
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07776509Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Dell Children's Medical Center - PIN, Austin
- Driscoll Children's Hospital, Corpus Christi
- McGovern Medical School, Houston
- og 4 flere
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- Amarillo Medical Specialists, Amarillo
- Velocity Clinical Res-Dallas, Dallas
- Care United Research, LLC, Forney
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07339423A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- IMA Clinical Research Austin, Austin
- Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
- Velocity Clinical Research, Dallas, Dallas
- og 5 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- UT Southwestern Medical Center, Dallas
- Juno Research, Houston
- Activian Clinical Research, Kingwood
- og 7 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, DeSoto
- Research Site, El Paso
- Research Site, Houston
- og 5 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- FutureSearch Trials of Neurology, Austin
- Sleep Therapy Research Center, San Antonio
- Consano Clinical Research, LLC, Shavano Park
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07369011Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- PharmaTex Research, LLC, Amarillo
- Austin Heart, Austin
- Velocity Clinical Research - Austin, Austin
- og 22 flere
RekruttererFase 3
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- The University of Texas Health Science Center at Houston, Bellaire
- Velocity Clinical Research, Dallas, Dallas
- UT Southwestern Medical Center, Dallas
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07321886Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- JCCT - Juno Bellaire Site, Bellaire
- Epic Medical Research - DeSoto, DeSoto
- Valley Institute of Research - Fort Worth, Fort Worth
- og 5 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07353931A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- IMA Clinical Research Austin, Austin
- FutureSearch Trials of Dallas, Dallas
- PlanIt Research, PLLC, Houston
- og 2 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 22. sep. 2026 · NCT07589608Semaglutide for Post-Smoking Cessation Weight Management
- The University of Texas at Austin, Austin
- The University of Texas Health Science Center at Houston, Houston
RekruttererFase 2Frivillige med god helbredstilstand velkomne
Alder 18 til 75 · Alle køn · Opdateret 21. sep. 2026 · NCT06173778A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Austin
- AURORA-1 Clinical Site, Brownsville
- AURORA-1 Clinical Site, DeSoto
- og 8 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Austin
- AURORA-2 Clinical Site, Brownsville
- AURORA-2 Clinical Site, DeSoto
- og 10 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- PharmaTex Research, LLC, Amarillo
- Austin Heart, Austin
- Javara Research, Conroe
- og 13 flere
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 16. sep. 2026 · NCT07037459A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Headlands Research Brownsville, Brownsville
- Velocity Clinical Research, Dallas
- South Texas Research Institute - Edinburg, Edinburg
- og 5 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Juno Research, Houston
- Southern Endocrinology Associates, Mesquite
- Texas Diabetes & Endocrinology, P.A., Round Rock
- og 2 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT06897475A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Bellaire Clinical Research, LLC, Bellaire
- South Texas Research Institute - Brownsville, Brownsville
- South Texas Clinical Research, Corpus Christi
- og 8 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351045First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
- Research Site, Webster
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 25 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT07815678AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Epic Medical Research, DeSoto
- Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
- Biorhythms Center for Integrative Sleep Medicine, El Paso
- og 3 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT07571005A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Austin
- ACCOMPLISH-2 Research Site, Farmers Branch
- ACCOMPLISH-2 Research Site, Houston
- og 4 flere
RekruttererFase 3Frivillige med god helbredstilstand velkomne
Alder 18 til 79 · Alle køn · Opdateret 11. sep. 2026 · NCT07654374Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Cedar Health Research, Dallas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07770841AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Epic Medical Research, DeSoto
- Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
- Biorhythms Center for Integrative Sleep Medicine, El Paso
- og 3 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07571109A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- IMA Clinical Research Austin, Austin
- Velocity Clinical Research, Dallas, Dallas
- FutureSearch Trials of Dallas, Dallas
- og 3 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT06143956A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Mercy Family Clinic, Dallas
- Velocity Clinical Research, Dallas, Dallas
- Biopharma Informatic, LLC, Houston
- og 5 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT07215559A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
- ICON, San Antonio
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 55 · Alle køn · Opdateret 4. sep. 2026 · NCT07767175A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Bellaire Dermatology Associates, Bellaire
- Modern Research Associates, PLLC, Dallas
- Center for Clinical Studies, Houston
- og 3 flere
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Amarillo
- Kailera Clinical Site, Brownsville
- Kailera Clinical Site, DeSoto
- og 5 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07284901Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.